Abstract
Hyperglycemia in hospitalized patients with coronavirus disease 2019 (COVID-19) is linked to increased morbidity and mortality. This article reports on a novel insulin titration protocol for the management of glucocorticoid-induced hyperglycemia in hospitalized patients with COVID-19. Sixty-five patients with COVID-19 and glucocorticoid-induced hyperglycemia admitted after the protocol implementation were matched 1:1 to patients admitted before the treatment protocol rollout for analysis. In a large, diverse health system, the protocol achieved reductions in hypoglycemic events without increasing hyperglycemia or insulin use.
Original language | English |
---|---|
Pages (from-to) | 378-385 |
Number of pages | 8 |
Journal | Clinical Diabetes |
Volume | 41 |
Issue number | 3 |
DOIs | |
State | Published - Jul 2023 |